• E-mail
• Print
• Comment
• Font Size
• Digg
• del.icio.us
• Discuss article

Amerinet Selects IsoAid to Provide Membership With Prostate Brachytherapy Products Under a Three-Year Agreement

Posted on: Thursday, 18 September 2008, 15:00 CDT

IsoAid, a premier provider of brachytherapy products, and Amerinet, a leading healthcare group purchasing organization (GPO), announced today that IsoAid has been awarded a three-year brachytherapy contract to provide Amerinet members with a complete line of brachytherapy products used primarily in the treatment of prostate cancer.

The agreement will begin on October 1, 2008 and run for a three-year term. The agreement offers Amerinet's membership competitive market pricing, and access to IsoAid's Advantage I-125(TM) and Advantage Pd-103(TM) seeds and related brachytherapy products.

IsoAid is a privately held Florida-based company with customers worldwide. IsoAid is one of the fastest growing companies in the field of brachytherapy and is the true manufacturer of Advantage I-125(TM) and Advantage Pd-103(TM) seeds with proven design, and proven dosimetry. Please visit www.isoaid.com for more information.

About Amerinet Inc.

As a leading national group purchasing organization, Amerinet strategically partners with healthcare providers to reduce costs and improve quality.

Through Amerinet's total spend management solutions and operational performance improvement tools and services, we assist providers in reducing costs, improving efficiencies and creating new revenue streams. Supported by a team of clinical, data and supply chain experts, Amerinet offers a comprehensive and competitive portfolio of product and service contracts designed to address members' specific needs.

Based in St. Louis, with offices in Salt Lake City, Utah, Providence, R.I., and Warrendale, Pa., Amerinet serves acute and non-acute healthcare providers nationwide. To learn more, visit www.amerinet-gpo.com.

Source: Business Wire

More News in this Category